An oncolytic poxvirus encoding hNIS, shows anti-tumor efficacy and allows tumor imaging in a liver cancer model.
Shyambabu ChaurasiyaHannah ValenciaZhifang ZhangSang-In KimAnnie YangJianming LuYanghee WooSusanne G WarnerNicholas J EdeYuman FongPublished in: Molecular cancer therapeutics (2023)
Oncolytic viruses (OVs) are live viruses that can selectively replicate in cancer cells. We have engineered an OV (CF33) to make it cancer-selective through the deletion of its J2R (thymidine kinase) gene. Additionally, this virus has been armed with a reporter gene, human sodium iodide symporter (hNIS), to facilitate non-invasive imaging of tumors using positron emission tomography (PET). In this study we evaluated the oncolytic properties of the virus (CF33-hNIS) in liver cancer model, and its usefulness in tumor imaging. The virus was found to efficiently kill liver cancer cells and the virus-mediated cell death exhibited characteristics of immunogenic death based on the analysis of 3 damage associate molecular patterns (DAMPs): calreticulin, ATP and HMGB1. Furthermore, local or systemic administration of a single dose of the virus showed anti-tumor efficacy against a liver cancer xenograft model in mice and significantly increased survival of treated mice. Lastly, PET scanning was performed following injection of the radioisotope I-124, for imaging of tumors, and a single dose of virus as low as 1E03 pfu, administered intratumorally (I.T.) or intravenously (I.V.), allowed for PET imaging of tumors. In conclusion, CF33-hNIS is safe and effective in controlling human tumor xenografts in nude mice, and it also facilitates non-invasive imaging of tumors.
Keyphrases
- positron emission tomography
- pet imaging
- high resolution
- computed tomography
- endothelial cells
- cystic fibrosis
- cell death
- oxidative stress
- pet ct
- disease virus
- metabolic syndrome
- genome wide
- type diabetes
- insulin resistance
- gene expression
- single molecule
- photodynamic therapy
- induced pluripotent stem cells
- young adults
- cell proliferation
- transcription factor
- fluorescence imaging